PDF-MannKind Resubmits New Drug Application to U.S. FDA for AFREZZA for th

Author : ellena-manuel | Published Date : 2016-07-23

October 14 2013 Adults with Diabetes VALENCIA Calif BUSINESS WIRE Oct 14 2013 MannKind Corporation Nasdaq MNKD today announced the resubmission on October 13 2013

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/416633" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "MannKind Resubmits New Drug Application ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

MannKind Resubmits New Drug Application to U.S. FDA for AFREZZA for th: Transcript

Download Document

Here is the link to download the presentation.
"MannKind Resubmits New Drug Application to U.S. FDA for AFREZZA for th"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.